All In MedTech

Device Trial Radar · NCT03516136

Safety and Performance of the EndoFast Reliant SCP in Vaginal Wall Reinforcement

A Retrospective Study for Collecting Data on the Safety and Performance of the EndoFast Reliant SCP in Vaginal Wall Reinforcement

Last checked: Nov 20, 2026Latest source record: May 17, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

84

Actual

Start

Jan 1, 2015

Primary completion

Dec 31, 2017

Study completion Dec 31, 2017

Sponsor

Lead sponsor
Allium, Ltd.Not on our public-company list
Sponsor type
Industry
First posted
May 4, 2018

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Single arm, single site, retrospective cohort Post Marketing Clinical Follow up Study Evaluating the Safety and Performance of the EndoFast Reliant SCP for apical support.

Conditions

  • Pelvic Organ Prolapse

Interventions

  • EndoFast Reliant SCPDevice

    POP repair procedure with the EndoFast Reliant SCP system

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety- procedure and device related complication rateTime frame: Up to 4 years

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.